$ACHV
ACHIEVE LIFE SCIENCES, INC.

2013 Q4 Form 10-Q Financial Statement

#000119312513432841 Filed on November 07, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q3
Revenue $8.600M $9.860M $6.570M
YoY Change -12.07% 50.08% 461.54%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.450M $2.470M $1.970M
YoY Change 20.1% 25.38% 34.93%
% of Gross Profit
Research & Development $13.20M $18.00M $12.90M
YoY Change -15.66% 39.62% 238.45%
% of Gross Profit
Depreciation & Amortization $70.00K $60.00K $30.00K
YoY Change 133.33% 100.0% 50.0%
% of Gross Profit
Operating Expenses $13.20M $18.00M $12.90M
YoY Change -15.66% 39.62% 144.69%
Operating Profit
YoY Change
Interest Expense $30.00K $30.00K $90.00K
YoY Change -57.14% -66.67% 80.0%
% of Operating Profit
Other Income/Expense, Net $359.0K $561.0K $2.370M
YoY Change -83.28% -76.33% -72.18%
Pretax Income -$6.680M -$10.05M -$5.920M
YoY Change 62.93% 69.76% -232.44%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.678M -$10.05M -$5.920M
YoY Change 62.76% 69.83% -232.44%
Net Earnings / Revenue -77.65% -101.97% -90.11%
Basic Earnings Per Share
Diluted Earnings Per Share -$668.0M -$1.005B -$592.0M
COMMON SHARES
Basic Shares Outstanding 14.71M shares 14.62M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $39.20M $46.80M $85.10M
YoY Change -48.01% -45.01% 22.8%
Cash & Equivalents $14.59M $12.95M $11.36M
Short-Term Investments $24.60M $33.80M $73.70M
Other Short-Term Assets $5.800M $2.700M $9.600M
YoY Change 52.63% -71.88% 152.63%
Inventory
Prepaid Expenses $5.770M
Receivables $8.657M $9.922M $1.100M
Other Receivables $200.0K $300.0K $0.00
Total Short-Term Assets $53.87M $59.71M $95.80M
YoY Change -32.82% -37.68% 29.46%
LONG-TERM ASSETS
Property, Plant & Equipment $397.0K $443.0K $200.0K
YoY Change 7.01% 121.5% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.111M $1.175M $1.100M
YoY Change -3.56% 6.82% 120.0%
Total Long-Term Assets $1.822M $1.932M $1.400M
YoY Change -0.82% 38.0% 100.0%
TOTAL ASSETS
Total Short-Term Assets $53.87M $59.71M $95.80M
Total Long-Term Assets $1.822M $1.932M $1.400M
Total Assets $55.69M $61.64M $97.20M
YoY Change -32.1% -36.59% 30.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $139.0K $39.00K $5.700M
YoY Change -89.54% -99.32% 280.0%
Accrued Expenses $11.78M $11.33M
YoY Change 181.91%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.100M $1.100M $1.500M
YoY Change 0.0% -26.67% 7.14%
Total Short-Term Liabilities $14.93M $14.37M $21.70M
YoY Change 29.23% -33.79% 13.61%
LONG-TERM LIABILITIES
Long-Term Debt $3.500M $3.700M $5.700M
YoY Change -18.6% -35.09% -12.31%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $3.500M $3.700M $5.700M
YoY Change -18.6% -35.09% -63.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.93M $14.37M $21.70M
Total Long-Term Liabilities $3.500M $3.700M $5.700M
Total Liabilities $18.48M $18.10M $27.40M
YoY Change 16.88% -33.96% -21.04%
SHAREHOLDERS EQUITY
Retained Earnings -$133.7M -$127.0M
YoY Change 31.27%
Common Stock $168.3M $167.9M
YoY Change 1.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $37.21M $43.54M $69.80M
YoY Change
Total Liabilities & Shareholders Equity $55.69M $61.64M $97.20M
YoY Change -32.1% -36.59% 30.12%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income -$6.678M -$10.05M -$5.920M
YoY Change 62.76% 69.83% -232.44%
Depreciation, Depletion And Amortization $70.00K $60.00K $30.00K
YoY Change 133.33% 100.0% 50.0%
Cash From Operating Activities -$7.540M -$10.23M -$12.94M
YoY Change -20.55% -20.94% 109.05%
INVESTING ACTIVITIES
Capital Expenditures -$20.00K $0.00 -$20.00K
YoY Change -88.89% -100.0% 100.0%
Acquisitions
YoY Change
Other Investing Activities $9.200M $4.410M $10.10M
YoY Change -43.9% -56.34% 1034.83%
Cash From Investing Activities $9.180M $4.410M $10.07M
YoY Change -43.44% -56.21% 1031.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 350.0K
YoY Change -100.0% 191.67%
NET CHANGE
Cash From Operating Activities -7.540M -10.23M -12.94M
Cash From Investing Activities 9.180M 4.410M 10.07M
Cash From Financing Activities 0.000 0.000 350.0K
Net Change In Cash 1.640M -5.820M -2.520M
YoY Change -75.67% 130.95% -51.35%
FREE CASH FLOW
Cash From Operating Activities -$7.540M -$10.23M -$12.94M
Capital Expenditures -$20.00K $0.00 -$20.00K
Free Cash Flow -$7.520M -$10.23M -$12.92M
YoY Change -19.23% -20.82% 109.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
4.11
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14707636 shares
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11362000
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14706260 shares
CY2013Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1587301 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14706260 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.42
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
985616 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1043678 shares
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q3 us-gaap Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance
DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
2381607 shares
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3475 shares
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
234000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2874000
us-gaap Costs And Expenses
CostsAndExpenses
49568000
CY2012Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
1084000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1329000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11556000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2637000
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1541000
CY2012Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3422000
CY2012Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
4253000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
66207000
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11334000
CY2013Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
1090000
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
78000
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
104000
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
39000
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
26000
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
14368000
CY2013Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
300000
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2640000
CY2013Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1357000
CY2013Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
548000
CY2013Q3 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
3728000
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
43543000
CY2013Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
167899000
CY2013Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
548000
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-127011000
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
15000
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
61639000
CY2013Q3 us-gaap Liabilities
Liabilities
18096000
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q3 us-gaap Assets Current
AssetsCurrent
59707000
CY2013Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
314000
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1175000
CY2013Q3 us-gaap Assets
Assets
61639000
CY2013Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
47091000
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12950000
CY2013Q3 us-gaap Short Term Investments
ShortTermInvestments
33827000
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9922000
CY2013Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2713000
CY2013Q3 us-gaap Cash
Cash
5723000
CY2013Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3000000
CY2013Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
295000
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
443000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28517000
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14656916 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14656916 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.34
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
804781 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4180000
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
165395000
CY2012Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
3422000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-101840000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
15000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
82016000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
3061 shares
CY2012Q4 us-gaap Liabilities
Liabilities
15809000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Assets Current
AssetsCurrent
80179000
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
314000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1152000
CY2012Q4 us-gaap Assets
Assets
82016000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18075000
CY2012Q4 us-gaap Short Term Investments
ShortTermInvestments
57308000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
714000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3755000
CY2012Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2700000
CY2012Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
327000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
371000
dei Trading Symbol
TradingSymbol
OGXI
dei Entity Registrant Name
EntityRegistrantName
ONCOGENEX PHARMACEUTICALS, INC.
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0000949858
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0115 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8702 pure
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
14.30
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M18D
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14675244 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.81
us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
45869 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28389000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.72
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
209282 shares
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-184000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7446000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
21911 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2900000 shares
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1019000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25168000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
31615000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
121000
us-gaap Investment Income Interest
InvestmentIncomeInterest
124000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-32000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9208000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3119000
us-gaap Net Income Loss
NetIncomeLoss
-25171000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
2874000
us-gaap Marketable Securities Realized Gain Loss Other Than Temporary Impairments Amount
MarketableSecuritiesRealizedGainLossOtherThanTemporaryImpairmentsAmount
0
us-gaap Share Based Compensation
ShareBasedCompensation
2490000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5125000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2100000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
7154000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
23247000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42122000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
55096000
us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-504000
us-gaap Depreciation
Depreciation
162000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1290000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
7000
ogxi Class Of Warrant Or Right Exercise Price Of Warrant Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantOrRights
20
ogxi Number Of Warrants Exercised
NumberOfWarrantsExercised
0 shares
ogxi Expiration Of Non Cancellable Operating Lease Agreement
ExpirationOfNonCancellableOperatingLeaseAgreement
2017
ogxi Maximum Maturity Period Of Short Term Investments
MaximumMaturityPeriodOfShortTermInvestments
P1Y
ogxi Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
15000
ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
21278000
ogxi Expiration Of Operating Lease Agreement
ExpirationOfOperatingLeaseAgreement
2014-09
ogxi Property And Equipment Acquired Under Lease Obligation
PropertyAndEquipmentAcquiredUnderLeaseObligation
24000
ogxi Maximum Maturity Period Of Cash And Cash Equivalents
MaximumMaturityPeriodOfCashAndCashEquivalents
P90D
ogxi Class Of Warrant Or Right Expiration Year And Month
ClassOfWarrantOrRightExpirationYearAndMonth
2015-10
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0096 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9547 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13141940 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-33996000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.29
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
116834 shares
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8705000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16976000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
84313000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7000
us-gaap Investment Income Interest
InvestmentIncomeInterest
227000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
144000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
182000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2742000
us-gaap Net Income Loss
NetIncomeLoss
-16995000
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
-63000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
114000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
19000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2522000
us-gaap Costs And Expenses
CostsAndExpenses
30052000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
169000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5749000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
54237000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-9126000
us-gaap Share Based Compensation
ShareBasedCompensation
1610000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-17155000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2000000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2494000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
53777000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-37415000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24303000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
460000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
47012000
us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-589000
us-gaap Depreciation
Depreciation
71000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-162000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
19000
ogxi Number Of Warrants Exercised
NumberOfWarrantsExercised
0 shares
ogxi Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
-22000
ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
10315000
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2600000 shares
CY2012Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14619842 shares
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.40
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5882000
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-24000
CY2012Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
86000
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2370000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-5920000
CY2012Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
38000
CY2012Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2308000
CY2012Q3 us-gaap Costs And Expenses
CostsAndExpenses
14860000
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1965000
CY2012Q3 us-gaap Share Based Compensation
ShareBasedCompensation
581000
CY2012Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
700000
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12895000
CY2012Q3 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
6570000
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14690984 shares
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.68
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18004000
CY2013Q3 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
9862000
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10030000
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11000
CY2013Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
33000
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
561000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-10054000
CY2013Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
24000
CY2013Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-539000
CY2013Q3 us-gaap Costs And Expenses
CostsAndExpenses
20477000
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2473000
CY2013Q3 us-gaap Share Based Compensation
ShareBasedCompensation
887000
CY2013Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
700000

Files In Submission

Name View Source Status
0001193125-13-432841-index-headers.html Edgar Link pending
0001193125-13-432841-index.html Edgar Link pending
0001193125-13-432841.txt Edgar Link pending
0001193125-13-432841-xbrl.zip Edgar Link pending
d589109d10q.htm Edgar Link pending
d589109dex311.htm Edgar Link pending
d589109dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ogxi-20130930.xml Edgar Link completed
ogxi-20130930.xsd Edgar Link pending
ogxi-20130930_cal.xml Edgar Link unprocessable
ogxi-20130930_def.xml Edgar Link unprocessable
ogxi-20130930_lab.xml Edgar Link unprocessable
ogxi-20130930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending